Bronchial asthma: dispelling myths

On 11 December, the world observes Bronchial Asthma Day, one of the most common chronic non-communicable diseases.

Nearly 300 million people on the planet have asthma, and the number is growing steadily (1). Today, Astrapharm aims to disprove the most common myths about bronchial asthma, which are sometimes still prevalent in our society, and to remind us how to control the disease.

Myth: Bronchial asthma is an inherited disease, so it can only occur in a family with a history of allergic diseases.
Truth: Their risk of developing asthma is indeed higher, but people without a family history of asthma have a greater than 10% chance of developing the disease.

Myth: Allergens are the only cause of asthma exacerbation.
Truth: Viral infections, exercise, stress, tobacco smoke, and taking certain medications can also provoke or exacerbate symptoms.

Myth: Since bronchial asthma is caused by allergens, antihistamines can be taken instead of glucocorticosteroids.
Truth: The use of anti-allergy drugs is only effective in the complex treatment of patients, it alleviates the course of concomitant allergic manifestations.

That is why the pharmaceutical company Astrapharm 2021 introduced to the pharmaceutical market of Ukraine tablet antihistamine drug with desloratadine – Astria.

The advantage of Astria it`s proven efficacy for patients with bronchial asthma. Indeed, studies confirm that montelukast (a leukotriene receptor antagonist) and desloratadine synergistically inhibit an early asthmatic reaction caused by an allergen (2).

Astria comes in the form of film-coated tablets that contain 5 mg of desloratadine.

The drug is available without a prescription.

Astrapharm – the art of helping people!

1. https://www.who.int/news-room/fact-sheets/detail/asthma
2. Effects of montelukast-desloratadine combination on early and late asthma responses Davis BE, Illamperuma C, Gauvreau GM, et al. Single-dose desloratadine and montelukast and allergen-induced late airway responses. Eur Respir J 2009;33(6):1302-308